Acute chest pain is a common presenting symptom in clinical practice, posing diagnostic challenges due to its diverse etiologies. A comprehensive approach to its evaluation is vital for timely and accurate diagnosis.
Initial evaluation should focus on rapid identification of life-threatening conditions. A detailed history, physical examination, and basic investigations like electrocardiogram (ECG) and chest X-ray can provide crucial diagnostic clues. High-risk features such as radiation of pain, associated symptoms, and risk factors for coronary artery disease should prompt urgent evaluation for acute coronary syndrome (ACS).
Biomarkers play an important role in diagnosing acute chest pain. High-sensitivity cardiac troponins are the preferred biomarkers for ACS, with a rise and/or fall in levels indicative of myocardial injury. Other biomarkers like brain natriuretic peptide (BNP) can be useful in diagnosing heart failure.
Imaging modalities further refine the diagnosis. Echocardiography can detect wall motion abnormalities suggestive of ACS and assess valvular pathology. Computed tomography (CT) angiography is a reliable tool for ruling out pulmonary embolism or aortic dissection. Cardiac magnetic resonance imaging (MRI) can identify myocarditis or takotsubo cardiomyopathy.
Risk stratification is crucial in guiding management. Tools like the HEART score can help in assessing the risk of major adverse cardiac events. Low-risk patients might be candidates for outpatient evaluation, while high-risk patients require hospitalization and further diagnostic testing.
Deciphering the cause of acute chest pain requires a systematic approach, integrating clinical assessment, biomarker evaluation, imaging studies, and risk stratification. This comprehensive approach ensures accurate diagnosis, timely intervention, and optimal patient outcomes.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Should the UK introduce targeted prostate cancer screening? The case for and against
3.
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
4.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
5.
Investigating the Relationship Between GERD and Anxiety/Depression.
1.
Building Physical Resilience in Chronic Blood Disorders
2.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
3.
Artificial Intelligence for Spatial Tumor Evolution Reconstruction
4.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
5.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Understanding Risk Factors Associated With Common Cancers
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation